2026 Specialty Measure Set

2026 MIPS Quality Measures for Oncology/Hematology

The 24 MIPS quality measures designated by CMS for the Oncology/Hematology specialty set. These are the measures oncology/hematology specialists are most likely to report on—though any MIPS-eligible measure can be submitted.

24measures
13high priority
22with benchmarks
10topped out
ID Measure eCQMType Status
MIPS 047Advance Care PlanHigh PriorityTopped Out
MIPS 102Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk ProstateCMS129v15High PriorityBenchmark
MIPS 130Documentation of Current Medications in the Medical RecordCMS68v15High PriorityTopped Out
MIPS 134Preventive Care and Screening: Screening for Depression and Follow-Up PlanCMS2v15ProcessTopped Out
MIPS 143Oncology: Medical and Radiation – Pain Intensity QuantifiedCMS157v14High PriorityTopped Out
MIPS 144Oncology: Medical and Radiation – Plan of Care for PainHigh PriorityTopped Out
MIPS 226Preventive Care and Screening: Tobacco Use: Screening and CessationCMS138v14ProcessTopped Out
MIPS 238Use of High-Risk Medications in Older AdultsCMS156v14High PriorityTopped Out
MIPS 250Radical Prostatectomy Pathology ReportingProcessTopped Out
MIPS 317Preventive Care and Screening: Screening for High Blood Pressure and Follow-UpCMS22v14ProcessTopped Out
MIPS 374Closing the Referral Loop: Receipt of Specialist ReportCMS50v14High PriorityTopped Out
MIPS 431Preventive Care and Screening: Unhealthy Alcohol Use: Screening & BriefProcessBenchmark
MIPS 450Appropriate Treatment for Patients with Stage I (T1c) – III HER2 PositiveHigh PriorityBenchmark
MIPS 451RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients withProcessBenchmark
MIPS 453Percentage of Patients who Died from Cancer Receiving Systemic Cancer-DirectedHigh PriorityBenchmark
MIPS 457Percentage of Patients who Died from Cancer Admitted to Hospice for Less than 3High PriorityBenchmark
MIPS 490Appropriate Intervention of Immune-Related Diarrhea and/or Colitis in Patients TreatedProcessBenchmark
MIPS 493Adult Immunization StatusProcessBenchmark
MIPS 495Ambulatory Palliative Care Patients’ Experience of Feeling Heard andHigh PriorityBenchmark
MIPS 503Gains in Patient Activation Measure (PAM) Scores at 12 MonthsHigh PriorityBenchmark
MIPS 506Positive PD-L1 Biomarker Expression Test Result Prior to First-Line Immune CheckpointHigh PriorityBenchmark
MIPS 507Appropriate Germline Testing for Ovarian Cancer PatientsProcessBenchmark

All Specialty Sets

Allergy/Immunology12Anesthesiology4Audiology10Cardiology22Certified Nurse Midwife11Chiropractic Medicine8Clinical Social Work19Dentistry2Dermatology11Diagnostic Radiology6Electrophysiology Cardiac Specialist2Emergency Medicine10Endocrinology16Family Medicine62Gastroenterology11General Surgery10Geriatrics22Hospitalists4Infectious Disease15Internal Medicine57Interventional Radiology13Mental/Behavioral Health20Nephrology17Neurology22Neurosurgical8Nutrition/Dietician8Obstetrics/Gynecology23Oncology/Hematology24Ophthalmology17Optometry6Orthopedic Surgery29Otolaryngology20Pathology7Pediatrics16Physical Medicine9Physical Therapy/Occupational Therapy25Plastic Surgery7Podiatry9Preventive Medicine20Pulmonology14Radiation Oncology4Rheumatology15Skilled Nursing Facility12Speech Language Pathology10Thoracic Surgery10Urgent Care11Urology21Vascular Surgery12

Need help selecting measures?

VBCA's clinical policy team helps practices choose the right measure mix based on patient population, benchmark opportunity, and program requirements.

Talk to Us →